Sign up to save your podcasts
Or
Share March 2025 Doc2Doc Podcast: Advancements in Retinal Drug Delivery
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
March 2025 Doc2Doc Podcast: Advancements in Retinal Drug Delivery
Send us a text
In this latest episode of the Doc2Doc podcast, hosts Dr. Sara LeMay, Retina Associates of Kentucky, and Dr. Aparna Shah, Bennett & Bloom Eye Centers, welcome retina specialist Dr. Jeremy Wolfe, Associated Retinal Consultants, to discuss Susvimo, a port delivery system for administering highly concentrated ranibizumab.
Dr. Wolfe explains its design, which allows for slow, sustained drug delivery into the vitreous cavity via simple diffusion. He details the surgical procedure, highlighting its learning curve and support from surgical device specialists, as well as the post-operative follow-up and refill process, which patients in clinical trials strongly preferred over regular intravitreal injections.
Dr. Wolfe also addresses the 2022 voluntary recall due to septum dislocation issues. While the procedure differs from standard retina surgeries, Dr. Wolfe believes it is well within the capabilities of retina specialists, paving the way for broader adoption.
The program is brought to you by our Corporate Sponsor, AbbVie. The opinions of the presenters and the content shared is not created by or necessarily endorsed by AbbVie.
"At AbbVie, we set our sights on a future where vision lasts a lifetime. With a legacy of more than 75 years in eye care, we’re proud to offer 125 eye care products that help to preserve and protect vision for patients around the world. We treat conditions from the front to the back of the eye, including glaucoma, ocular surface disease, and retinal diseases. For more information, visit: https://www.abbvie.com/science/areas-of-focus/eye-care.html."
Copyright ©️ 2025 EyeCare Partners, LLC. All rights reserved.
View all episodes
By EyeCare PartnersSend us a text
In this latest episode of the Doc2Doc podcast, hosts Dr. Sara LeMay, Retina Associates of Kentucky, and Dr. Aparna Shah, Bennett & Bloom Eye Centers, welcome retina specialist Dr. Jeremy Wolfe, Associated Retinal Consultants, to discuss Susvimo, a port delivery system for administering highly concentrated ranibizumab.
Dr. Wolfe explains its design, which allows for slow, sustained drug delivery into the vitreous cavity via simple diffusion. He details the surgical procedure, highlighting its learning curve and support from surgical device specialists, as well as the post-operative follow-up and refill process, which patients in clinical trials strongly preferred over regular intravitreal injections.
Dr. Wolfe also addresses the 2022 voluntary recall due to septum dislocation issues. While the procedure differs from standard retina surgeries, Dr. Wolfe believes it is well within the capabilities of retina specialists, paving the way for broader adoption.
The program is brought to you by our Corporate Sponsor, AbbVie. The opinions of the presenters and the content shared is not created by or necessarily endorsed by AbbVie.
"At AbbVie, we set our sights on a future where vision lasts a lifetime. With a legacy of more than 75 years in eye care, we’re proud to offer 125 eye care products that help to preserve and protect vision for patients around the world. We treat conditions from the front to the back of the eye, including glaucoma, ocular surface disease, and retinal diseases. For more information, visit: https://www.abbvie.com/science/areas-of-focus/eye-care.html."
Copyright ©️ 2025 EyeCare Partners, LLC. All rights reserved.